Private Equity 3 Days

Last updated: June 17, 2026, 8:30 PM ET

Board Moves & Capital Deployments

Former Sequoia partner joined SpaceX’s board as the rocket maker completed the largest IPO in history, underscoring the growing crossover between venture talent and public‑market governance. In the infrastructure arena, KPS Capital injected equity into Jennmar, while existing shareholder Falcon Point retained a meaningful minority stake, positioning the provider for expansion into high‑growth construction markets. Simultaneously, Altaris announced a $375 million take‑private of Simulations Plus, pricing the deal at $18.50 per share and signalling continued private‑equity appetite for niche health‑tech platforms that can leverage post‑pandemic data analytics.

Mega‑Cap Consolidations

A Blackstone‑led consortium that includes Apollo and KKR secured control of Medallia after Thoma Bravo absorbed a $5 billion loss, reflecting a broader trend of large sponsors stepping in to rescue software assets with recurring‑revenue models. Across the fintech spectrum, General Atlantic entered exclusive talks to lead a $2 billion‑plus round for China’s Kling AI, targeting the video‑generation business of Kuaishou Technology and highlighting private‑equity interest in generative‑AI applications beyond the United States. Meanwhile, CPP Investments committed up to $715 million to expand Ctrl S’s data‑centre platform in India, reinforcing the pension fund’s strategy to capture growth in the world’s fastest‑expanding digital‑infrastructure market.

Sector‑Focused Acquisitions

TPG acquired Waste Eliminator and Liberty Waste Solutions from Allied Industrial Partners, creating a consolidated waste‑management platform that can benefit from rising ESG‑driven demand for circular‑economy services. In the aerospace niche, KKR added another $1.4 billion to its Altavair aircraft‑leasing partnership, bringing its total commitment to over $8 billion and cementing the firm’s role as a primary source of capital for the leasing sector’s post‑pandemic recovery. Health‑care saw further consolidation as Belmont Medical Technologies, backed by Audax, purchased Arcos Inc, expanding its fluid‑resuscitation and temperature‑management portfolio ahead of anticipated demand spikes from aging populations.

Secondary Market Activity & Fundraising

Flexstone announced the acquisition of Glouston, creating a combined secondaries platform with more than $15 billion in assets under management and broadening its U.S. footprint. Parallelly, GIC moved to sell up to $2 billion of private‑credit assets, tapping a booming secondary market that offers liquidity to sovereign investors amid tightening global credit conditions. In fundraising news, Clearlake closed its eighth flagship fund at $14.8 billion, a sizable haul that underscores investor confidence in large‑cap managers even as capital raising cycles lengthen.

Credit & Debt Innovations

Blackstone launched Sable Pointe Credit Strategies, a dedicated asset‑based lending platform aimed at deepening its exposure to the fast‑growing private‑credit space, particularly for collateral‑rich middle‑market deals. On the corporate‑finance front, Ancestry, owned by Blackstone, lined up a $2.25 billion loan to refinance existing debt, reflecting a broader trend of private‑equity‑backed companies leveraging leveraged‑loan markets to optimize balance sheets. Additionally, banks vied to assemble roughly £5 billion in financing for EQT’s potential take‑private of Intertek, highlighting the appetite for large‑scale debt packages to fund strategic carve‑outs in the product‑testing sector.

Strategic Stakes & Emerging Opportunities

Investcorp took a strategic stake in IT distributor Metra, securing a foothold in the MENA region’s fast‑growing technology supply chain. In a parallel move, L Catterton‑backed Birkenstock prepared a €900 million bond issuance to fund share buy‑backs, illustrating how consumer‑brand owners are turning to capital markets for shareholder returns. Finally, Prime Radiant Partners made its first investment, committing $50 million to Cellares, signaling the emergence of specialist private‑equity advisory firms focusing on early‑stage life‑science ventures as the sector seeks fresh growth capital.